These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3941408)

  • 1. Imidazo[4,5-c]pyridines (3-deazapurines) and their nucleosides as immunosuppressive and antiinflammatory agents.
    Krenitsky TA; Rideout JL; Chao EY; Koszalka GW; Gurney F; Crouch RC; Cohn NK; Wolberg G; Vinegar R
    J Med Chem; 1986 Jan; 29(1):138-43. PubMed ID: 3941408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity.
    Cristalli G; Vittori S; Eleuteri A; Grifantini M; Volpini R; Lupidi G; Capolongo L; Pesenti E
    J Med Chem; 1991 Jul; 34(7):2226-30. PubMed ID: 2066996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antiproliferative and antiviral activity of imidazo[4,5-d]isothiazole nucleosides as 5:5 fused analogs of nebularine and 6-methylpurine ribonucleoside.
    Swayze EE; Drach JC; Wotring LL; Townsend LB
    J Med Chem; 1997 Feb; 40(5):771-84. PubMed ID: 9057864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
    Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
    Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research on heterocyclic compounds. XV. Substitution influence on the pharmacological activity in a series of imidazo[1,2-a]pyridines.
    Abignente E; Arena F; Avara P; Biniecka M; Luraschi E; Marmo E; Cazzola M; Filippelli W
    Farmaco Sci; 1983 Dec; 38(12):911-28. PubMed ID: 6607848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some reactions of 2-cyanomethylimidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
    Bukowski L; Janowiec M; Zwolska-Kwiek Z; Andrzejczyk Z
    Pharmazie; 1998 Jun; 53(6):373-6. PubMed ID: 9675766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.
    Temple C; Rose JD; Comber RN; Rener GA
    J Med Chem; 1987 Oct; 30(10):1746-51. PubMed ID: 3656351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cell growth inhibition, and antitumor screening of 2-(p-n-butylanilino)purines and their nucleoside analogues.
    Wright GE; Dudycz LW; Kazimierczuk Z; Brown NC; Khan NN
    J Med Chem; 1987 Jan; 30(1):109-16. PubMed ID: 3806587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues.
    Papadakis G; Gerasi M; Snoeck R; Marakos P; Andrei G; Lougiakis N; Pouli N
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33022923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents.
    Nagahara K; Anderson JD; Kini GD; Dalley NK; Larson SB; Smee DF; Jin A; Sharma BS; Jolley WB; Robins RK
    J Med Chem; 1990 Jan; 33(1):407-15. PubMed ID: 2153211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent.
    Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of 3-substituted imidazo[1,2-a]pyridines as antiulcer agents.
    Starrett JE; Montzka TA; Crosswell AR; Cavanagh RL
    J Med Chem; 1989 Sep; 32(9):2204-10. PubMed ID: 2769690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and tuberculostatic activity of some derivatives of imidazo [4, 5-b]pyridine-1-carboxylic acid.
    Bukowski L
    Pol J Pharmacol Pharm; 1984; 36(6):683-8. PubMed ID: 6442935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases.
    Ručilová V; Świerczek A; Vanda D; Funk P; Lemrová B; Gawalska A; Bucki A; Nowak B; Zadrożna M; Pociecha K; Soural M; Wyska E; Pawłowski M; Chłoń-Rzepa G; Zajdel P
    Eur J Med Chem; 2021 Jan; 209():112854. PubMed ID: 33022582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azapurine nucleosides. 1. Synthesis and antitumor activity of certain 3- -D-ribofuranosyl- and 2'-deoxy-D-ribofuranosyl-v-triazolo(4,5-d)pyrimidines.
    Hutzenlaub W; Tolman RL; Robins RK
    J Med Chem; 1972 Sep; 15(9):879-83. PubMed ID: 5051002
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1).
    Martin JA; Bushnell DJ; Duncan IB; Dunsdon SJ; Hall MJ; Machin PJ; Merrett JH; Parkes KE; Roberts NA; Thomas GJ
    J Med Chem; 1990 Aug; 33(8):2137-45. PubMed ID: 2165161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridines.
    Kaminski JJ; Bristol JA; Puchalski C; Lovey RG; Elliott AJ; Guzik H; Solomon DM; Conn DJ; Domalski MS; Wong SC
    J Med Chem; 1985 Jul; 28(7):876-92. PubMed ID: 4009611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Methyl-1H-2-imidazo[4,5-b]pyridinecarboxylic acid and some of its derivatives with suspected antituberculotic activity.
    Bukowski L; Janowiec M
    Pharmazie; 1996 Jan; 51(1):27-30. PubMed ID: 8999430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotonic agents. 1. Novel 8-aryl-substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents.
    Davey D; Erhardt PW; Lumma WC; Wiggins J; Sullivan M; Pang D; Cantor E
    J Med Chem; 1987 Aug; 30(8):1337-42. PubMed ID: 3039131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on heterocyclic compounds. XIX--2-Methylimidazo[1,2-a]pyridine-3-acetic acids.
    Abignente E; Arena F; Luraschi E; Saturnino C; Marmo E; Russo S; Magliulo R
    Farmaco Sci; 1986 Feb; 41(2):119-30. PubMed ID: 3486134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.